[
  {
    "ts": "2025-11-21T18:13:00+00:00",
    "headline": "AI Stocks Are Taking a Beating. What to Buy Instead.",
    "summary": "November has been NO-vember when it comes to tech stocks.  Investors are shunning artificial-intelligence leaders and other momentum names.  Investors seem to be embracing drug stocks, insurers, and medical equipment companies again.",
    "url": "https://www.barrons.com/articles/ai-falls-stocks-winners-diversify-c789e4bc?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "537b6d6e-dd35-35f7-98b2-e6786302d1fc",
      "content": {
        "id": "537b6d6e-dd35-35f7-98b2-e6786302d1fc",
        "contentType": "STORY",
        "title": "AI Stocks Are Taking a Beating. What to Buy Instead.",
        "description": "",
        "summary": "November has been NO-vember when it comes to tech stocks.  Investors are shunning artificial-intelligence leaders and other momentum names.  Investors seem to be embracing drug stocks, insurers, and medical equipment companies again.",
        "pubDate": "2025-11-21T18:13:00Z",
        "displayTime": "2025-11-21T18:13:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/537b6d6e-dd35-35f7-98b2-e6786302d1fc/ai-stocks-are-taking-a.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/da7b0ec7c599c23e55667f4234c5bbd4",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z0LW1Ng.gq7ggQkV90FTmg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/da7b0ec7c599c23e55667f4234c5bbd4.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E6fg3SmwHgkvW5KYBBCrZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/da7b0ec7c599c23e55667f4234c5bbd4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/ai-falls-stocks-winners-diversify-c789e4bc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "EXPE"
            },
            {
              "symbol": "AKAM"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "SOLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T23:51:00+00:00",
    "headline": "AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to",
    "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "15929d4c-b37e-3fd3-bc4e-8ad4ace5531e",
      "content": {
        "id": "15929d4c-b37e-3fd3-bc4e-8ad4ace5531e",
        "contentType": "STORY",
        "title": "AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to",
        "pubDate": "2025-11-21T23:51:00Z",
        "displayTime": "2025-11-21T23:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ABBV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K222hrzb0FJJlqrDZzsz7w--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cD3IChyAhZhexmnMXW7jMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "BMRN"
            },
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]